Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies

MaCL with anti-beta-2 activity that was obtained from patients with APS may interfere in the activation of the contact complex during pregnancy.